内部人交易记录
其他尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the full record of transactions filed by Khan Najat. Officer active across 1 company, notably Recursion Pharmaceuticals, INC.. Cumulatively, 12 reports have been recorded. Split: 0 buy · 3 sells. Total volume traded: €618k. Activity tracked since 1 August 2024. The latest transaction was disclosed on 8 September 2026 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Khan Najat
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报12 总计
22,408 股@ US$3.51760.0043% mcap6.9% 占其流量Class A Common StockSEC:0001601830-26-000105:0
80,498 股@ US$3.160.015% mcap24.2% 占其流量Class A Common StockSEC:0002020969-26-000006:0
28,298 股@ US$3.345111.9% 占其流量Class A Common StockSEC:0001601830-26-000048:0
14,280 股@ US$3.496.1% 占其流量Class A Common StockSEC:0001601830-26-000019:0
1,673,546 股0Class A Common StockSEC:0001601830-26-000014:0
124,403 股@ US$4.409883.1% 占其流量Class A Common StockSEC:0001601830-25-000176:0
17,584 股@ US$4.1465.7% 占其流量Class A Common StockSEC:0002020969-25-000006:0
84,925 股0Class A Common StockSEC:0002020969-25-000004:0
3,789 股@ US$5.6456.0% 占其流量Class A Common StockSEC:0001601830-25-000131:0
3,796 股@ US$4.25100.0% 占其流量Class A Common StockSEC:0001601830-25-000084:0
210,113 股0Class A Common StockSEC:0001628280-25-004086:0
496,972 股0Class A Common StockSEC:0001601830-24-000106:0
About Khan Najat
Khan Najat is linked to Recursion Pharmaceuticals, INC. on XNAS as CEO and President. The declarant has 10 filings in total. Across the 10 sampled filings, they cover the period from 2024-08-05 to 2026-03-11, with 0 in buys and 550705 in sells, and the modal transaction nature is Retenue fiscale.